Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants

Texto completo
Autor(es):
Mezzacappa, M. A. [1] ; Facchini, F. P. [1] ; Pinto, A. C. [1] ; Cassone, A. E. L. [1] ; Souza, D. S. ; Bezerra, M. A. C. ; Albuquerque, D. M. [2] ; Saad, S. T. O. [2] ; Costa, F. F. [2]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, UNICAMP, Dept Pediat, Sch Med Sci, Div Neonatol, BR-13083881 Sao Paulo - Brazil
[2] Univ Estadual Campinas, UNICAMP, Hematol & Hemotherapy Ctr, Dept Internal Med, Sch Med Sci, Hemoctr, BR-13083881 Sao Paulo - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: Journal of Perinatology; v. 30, n. 12, p. 819-826, DEC 2010.
Citações Web of Science: 10
Resumo

Objective: To identify clinical and genetic risk factors for moderate hyperbilirubinemia during the first week of life. Study Design: Using univariate and multivariate multiple regression analyses, the RR for clinical factors, the African variant of glucose-6-phosphate dehydrogenase (G6PD) deficiency (G202A/A376G), and (TA)(n) UGT1A1 polymorphisms were established in a cohort of 608 Brazilian newborn infants. Hyperbilirubinemia was monitored until 134.5 +/- 49.8 h of life (IQR, 111.0 to 156.7). The dependent variable was total bilirubinemia (TB) >= 12.9 mg per 100 ml estimated by transcutaneous or plasma bilirubin measurements. Result: The African variant of G6PD deficiency and (TA)(7)/(TA)(7) and (TA)(7)/(TA)(8) polymorphisms present in 6.1 and 12.0% of newborns, respectively, were not risk factors for moderate hyperbilirubinemia. Coexpression of G6DP deficiency and UGT1A1 polymorphisms occurred in 0.49% of the subjects. Independent clinical predictors for TB >= 12.9mg per 100 ml were gestational age <38 weeks and reference curve percentiles >P40th. Conclusion: In this study, G6PD deficiency and UGT1A1 gene promoter polymorphisms were not risk factors for moderate hyperbilirubinemia. Genetic factors may vary considerably in importance among different populations. Journal of Perinatology (2010) 30, 819-826; doi: 10.1038/jp.2010.48; published online 8 April 2010 (AU)

Processo FAPESP: 06/60917-1 - Prevalência da deficiência de G6PD e da Síndrome de Gilbert em recém-nascidos com idade gestacional >= 35 semanas e peso ao nascer >= 2000 gramas: associação com hiperbilirrubinemia neonatal
Beneficiário:Maria Aparecida Marques dos Santos Mezzacappa
Modalidade de apoio: Auxílio à Pesquisa - Regular